20/20 Biolabs, Inc.

AIDX·NASDAQ·$1.02Share Price as of 11/2·$6MMarket Cap as of 11/2

Financials

10-QQ2 ended 06/30/2608/14/26 10-QQ1 ended 03/31/2605/20/26 10-KFY 202503/31/26

Disclosures

8-KCurrent report09/18/26 8-KCurrent report09/10/26 8-KCurrent report09/02/26 8-KCurrent report08/19/26 8-KCurrent report08/17/26

Prospectuses and Registrations

424B3Prospectus08/17/26 424B3Prospectus08/17/26 424B3Prospectus05/21/26 424B3Prospectus05/21/26 424B3Prospectus04/28/26

Proxies

DEF 14ADefinitive proxy10/21/26 DEFA14AAdditional proxy materials10/21/26 PRE 14APreliminary proxy10/06/26 DEFA14AAdditional proxy materials08/19/26 DEF 14ADefinitive proxy06/23/26

Ownership

Form 4Insider transaction04/06/26 Form 4Insider transaction04/06/26 SC 13DBeneficial ownership03/10/26 SC 13GBeneficial ownership03/10/26 Form 4Insider transaction03/04/26

Other

NT 10-QLate filing notification (10-Q)05/15/26 EFFECTRequest for effectiveness04/10/26 EFFECTRequest for effectiveness04/09/26 CORRESPCorrespondence with the SEC04/08/26 UPLOADLetter from the SEC04/08/26